IRCCS Istituto Ortopedico Galeazzi, Laboratory of Clinical Chemistry and Microbiology, Via R. Galeazzi 4, 20161, Milan, Italy.
IRCCS Istituto Ortopedico Galeazzi, Chirurgia Ricostruttiva e delle Infezioni osteo-articolari (C.R.I.O), Via R. Galeazzi 4, 20161, Milan, Italy.
BMC Infect Dis. 2021 May 4;21(1):416. doi: 10.1186/s12879-021-06113-8.
Prosthetic joint infection (PJI) is one of the most feared complications following total arthroplasty surgeries. Gram-positive bacteria are the most common microorganisms implicated in PJIs, while infections mediated by fungi only account for 1% of cases. When dealing with PJIs, a two-stage revision arthroplasty is widely used. Briefly, a spacer is introduced until re-implantation of the definitive prosthesis to provide skeleton stabilization while delivering antibiotics in the site of the infection. Sometimes, antimicrobial therapy may fail, but the isolation of a second microorganism from the spacer is uncommon and even less frequent that of a yeast.
Here is described a case of a 75-year-old woman who underwent two-stage revision surgery of the left hip prosthesis secondary to a Staphylococcus capitis infection, whose spacer was found to be infected by Candida albicans at a later time. Briefly, the patient underwent revision surgery of the hip prosthesis for a suspected PJI. After the debridement of the infected tissue, an antibiotic-loaded spacer was implanted. The microbiological analysis of the periprosthetic tissues and the implant depicted a S. capitis infection that was treated according to the antimicrobial susceptibility profile of the clinical isolate. Three months later, the patient was admitted to the emergency room due to local inflammatory signs. Synovial fluid was sent to the laboratory for culture. No evidence of S. capitis was detected, however, a yeast was identified as Candida albicans. Fifteen days later, the patient was hospitalized for the removal of the infected spacer. Microbiological cultures confirmed the results of the synovial fluid analysis. According to the susceptibility profile, the patient was treated with fluconazole (400 mg/day) for 6 months. Seven months later, the patient underwent second-stage surgery. The microbiological tests on the spacer were all negative. After 12 months of follow-up, the patient has fully recovered and no radiological signs of infection have been detected.
Given the exceptionality of this complication, it is important to report these events to better understand the clinical outcomes after the selected therapeutic options to prevent and forestall the development of either bacterial or fungal spacer infections.
人工关节感染(PJI)是全关节置换术后最可怕的并发症之一。革兰氏阳性菌是最常见的引起 PJI 的微生物,而真菌感染仅占病例的 1%。在处理 PJI 时,广泛使用两阶段翻修术。简而言之,在感染部位植入抗生素的同时,引入间隔物以提供骨骼稳定性,直到最终假体的再植入。有时,抗菌治疗可能会失败,但从间隔物中分离出第二种微生物并不常见,甚至比酵母更不常见。
这里描述了一位 75 岁女性的病例,她因头葡萄球菌感染而行左侧髋关节假体的两阶段翻修手术,后来发现其间隔物被白色念珠菌感染。简而言之,患者因疑似 PJI 而行髋关节假体翻修手术。在清除感染组织后,植入了载抗生素的间隔物。对假体周围组织和植入物的微生物分析显示为头葡萄球菌感染,根据临床分离株的药敏谱进行了治疗。三个月后,患者因局部炎症体征而入住急诊室。将滑膜液送到实验室进行培养。未检测到头葡萄球菌,但鉴定出一种酵母为白色念珠菌。十五天后,患者因感染间隔物而住院。微生物培养证实了滑膜液分析的结果。根据药敏谱,患者接受氟康唑(400mg/天)治疗 6 个月。七个月后,患者进行了第二阶段手术。间隔物的微生物学检查均为阴性。在 12 个月的随访后,患者已完全康复,未发现感染的放射学迹象。
鉴于这种并发症的罕见性,报告这些事件对于更好地了解所选治疗方案后的临床结果至关重要,以防止和阻止细菌或真菌间隔物感染的发生。